Stay updated on SPRINTER Clinical Trial
Sign up to get notified when there's something new on the SPRINTER Clinical Trial page.

Latest updates to the SPRINTER Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden message and a Home link, indicating restricted access, and replaces the previous rich study-detail content with a minimal error page.SummaryDifference18%

- Check20 days agoChange DetectedTel Litwinsky, Israel, 5265601 was added to the study's locations. Qiryat Krinitzi, Israel, 5265601 was removed from the study's locations.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded recruitment site Qiryat Krinitzi, Israel (5265601) and updated the study document to revision v3.6.6. Removed Tel Litwinsky, Israel (5265601) as a location and updated from revision v3.6.5.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision bumped from v3.6.4 to v3.6.5, indicating a newer release of the page content. This update appears to be a metadata/version change rather than a change to the study details or terms presented on the page.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small update to the page’s documentation/versioning rather than any change to study content.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision stamp has been updated from v3.6.2 to v3.6.3. This indicates a newer version of the study listing has been published.SummaryDifference0.0%

Stay in the know with updates to SPRINTER Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINTER Clinical Trial page.